Go Pro
→ The dollar reset no one told you about (From Porter & Company) (Ad)tc pixel Free FDBK Stock Alerts

Feedback (FDBK) Competitors

Feedback logo
GBX 6.40 -0.35 (-5.19%)
As of 03:36 AM Eastern
Compare

FDBK vs. INHC, IQAI, DVRG, SENS, and TRLS

Should you buy Feedback stock or one of its competitors? MarketBeat compares Feedback with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Feedback include Induction Healthcare Group (INHC), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), and Trellus Health (TRLS). These companies are all part of the "health information services" industry.

How does Feedback compare to Induction Healthcare Group?

Feedback (LON:FDBK) and Induction Healthcare Group (LON:INHC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

34.2% of Feedback shares are owned by institutional investors. Comparatively, 46.3% of Induction Healthcare Group shares are owned by institutional investors. 8.0% of Feedback shares are owned by company insiders. Comparatively, 54.6% of Induction Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Induction Healthcare Group has higher revenue and earnings than Feedback. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£849.62K3.46-£10.84M-£15.74N/A
Induction Healthcare Group£12.57M0.72-£5.12M-£5.54N/A

Induction Healthcare Group has a net margin of -23.86% compared to Feedback's net margin of -845.25%. Induction Healthcare Group's return on equity of -14.58% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-845.25% -135.17% -22.99%
Induction Healthcare Group -23.86%-14.58%-7.32%

In the previous week, Feedback had 1 more articles in the media than Induction Healthcare Group. MarketBeat recorded 1 mentions for Feedback and 0 mentions for Induction Healthcare Group. Feedback's average media sentiment score of 0.00 equaled Induction Healthcare Group'saverage media sentiment score.

Company Overall Sentiment
Feedback Neutral
Induction Healthcare Group Neutral

Feedback has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market. Comparatively, Induction Healthcare Group has a beta of -0.41, suggesting that its stock price is 141% less volatile than the broader market.

Summary

Induction Healthcare Group beats Feedback on 8 of the 12 factors compared between the two stocks.

How does Feedback compare to IQ-AI?

IQ-AI (LON:IQAI) and Feedback (LON:FDBK) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

34.2% of Feedback shares are held by institutional investors. 66.0% of IQ-AI shares are held by insiders. Comparatively, 8.0% of Feedback shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

IQ-AI has a net margin of -77.52% compared to Feedback's net margin of -845.25%. Feedback's return on equity of -135.17% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
IQ-AI-77.52% -140.75% -22.03%
Feedback -845.25%-135.17%-22.99%

In the previous week, Feedback had 1 more articles in the media than IQ-AI. MarketBeat recorded 1 mentions for Feedback and 0 mentions for IQ-AI. IQ-AI's average media sentiment score of 0.00 equaled Feedback'saverage media sentiment score.

Company Overall Sentiment
IQ-AI Neutral
Feedback Neutral

IQ-AI has a beta of 2.25, suggesting that its stock price is 125% more volatile than the broader market. Comparatively, Feedback has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market.

IQ-AI has higher earnings, but lower revenue than Feedback.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IQ-AI£538.19K3.30N/AN/AN/A
Feedback£849.62K3.46-£10.84M-£15.74N/A

Summary

Feedback beats IQ-AI on 6 of the 10 factors compared between the two stocks.

How does Feedback compare to DeepVerge?

Feedback (LON:FDBK) and DeepVerge (LON:DVRG) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

34.2% of Feedback shares are held by institutional investors. Comparatively, 4.2% of DeepVerge shares are held by institutional investors. 8.0% of Feedback shares are held by company insiders. Comparatively, 9.5% of DeepVerge shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Feedback has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market. Comparatively, DeepVerge has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market.

DeepVerge has a net margin of -19.81% compared to Feedback's net margin of -845.25%. DeepVerge's return on equity of -10.27% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-845.25% -135.17% -22.99%
DeepVerge -19.81%-10.27%-5.56%

In the previous week, Feedback had 1 more articles in the media than DeepVerge. MarketBeat recorded 1 mentions for Feedback and 0 mentions for DeepVerge. Feedback's average media sentiment score of 0.00 equaled DeepVerge'saverage media sentiment score.

Company Overall Sentiment
Feedback Neutral
DeepVerge Neutral

DeepVerge has higher revenue and earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than DeepVerge, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£849.62K3.46-£10.84M-£15.74N/A
DeepVerge£12.41M0.00-£2.46M-£0.01N/A

Summary

DeepVerge beats Feedback on 8 of the 11 factors compared between the two stocks.

How does Feedback compare to Sensyne Health?

Feedback (LON:FDBK) and Sensyne Health (LON:SENS) are both small-cap health information services industry companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

In the previous week, Feedback had 1 more articles in the media than Sensyne Health. MarketBeat recorded 1 mentions for Feedback and 0 mentions for Sensyne Health. Feedback's average media sentiment score of 0.00 equaled Sensyne Health'saverage media sentiment score.

Company Overall Sentiment
Feedback Neutral
Sensyne Health Neutral

Sensyne Health has a net margin of 0.00% compared to Feedback's net margin of -845.25%. Sensyne Health's return on equity of 0.00% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-845.25% -135.17% -22.99%
Sensyne Health N/A N/A N/A

34.2% of Feedback shares are held by institutional investors. 8.0% of Feedback shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Sensyne Health has higher revenue and earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than Sensyne Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£849.62K3.46-£10.84M-£15.74N/A
Sensyne Health£7.81M0.00N/A-£22.10N/A

Summary

Sensyne Health beats Feedback on 5 of the 9 factors compared between the two stocks.

How does Feedback compare to Trellus Health?

Feedback (LON:FDBK) and Trellus Health (LON:TRLS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

Trellus Health has lower revenue, but higher earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than Trellus Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£849.62K3.46-£10.84M-£15.74N/A
Trellus Health£359K1.44-£7.98M-£5.00N/A

In the previous week, Feedback had 1 more articles in the media than Trellus Health. MarketBeat recorded 1 mentions for Feedback and 0 mentions for Trellus Health. Feedback's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score.

Company Overall Sentiment
Feedback Neutral
Trellus Health Neutral

34.2% of Feedback shares are owned by institutional investors. Comparatively, 1.6% of Trellus Health shares are owned by institutional investors. 8.0% of Feedback shares are owned by insiders. Comparatively, 9.6% of Trellus Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Feedback has a net margin of -845.25% compared to Trellus Health's net margin of -6,826.32%. Trellus Health's return on equity of -49.78% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-845.25% -135.17% -22.99%
Trellus Health -6,826.32%-49.78%-22.76%

Feedback has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market. Comparatively, Trellus Health has a beta of 2.509, meaning that its share price is 151% more volatile than the broader market.

Summary

Trellus Health beats Feedback on 7 of the 12 factors compared between the two stocks.

Get Feedback News Delivered to You Automatically

Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FDBK vs. The Competition

Export
MetricFeedbackHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£2.94M£309.87M£7.05B£2.85B
Dividend Yield4.56%6.07%2.68%6.16%
P/E Ratio-0.43301.8527.11368.21
Price / Sales3.46141.68587.9284,612.73
Price / Cash1.1247.1429.2227.87
Price / Book0.127.5710.757.49
Net Income-£10.84M-£22.78M£3.58B£5.89B
7 Day Performance-1.46%-0.29%-2.06%-0.19%
1 Month PerformanceN/A0.58%3.32%-0.99%
1 Year Performance-52.48%-8.77%26.36%61.68%

Feedback Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FDBK
Feedback
N/AGBX 6.40
-5.2%		N/A-52.5%£2.80M£849.62KN/A24
INHC
Induction Healthcare Group
N/AGBX 9.75
flat		N/A+0.0%£9.00M£12.57MN/A74
IQAI
IQ-AI
N/AGBX 0.80
flat		N/A+0.0%£1.77M£538.19KN/A6
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41MN/A73
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81MN/A70

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:FDBK) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
They told you not to miss this one
The largest companies in the SP 500 are now more overvalued relative to fundamentals than they were at the abs...
Thor Metals | Sponsoredtc pixel
Forget SpaceX, this is Elon’s Next Breakthrough
Jeff Brown and Marc Chaikin - two investors who called Nvidia a decade ago - say Elon Musk's newly filed AI pa...
Brownstone Research | Sponsoredtc pixel
When I found Rolls-Royce under $2, most people thought I was crazy
In 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...
Monument Traders Alliance | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel